Depression and Anxiety Trial, Recruiting (NCT06652503)

Depression and Anxiety Trial, Recruiting NCT06652503 Sponsor: Nova Southeastern University Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT06652503 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older who are currently enrolled as undergraduate students at NSU (Nova Southeastern University)

Who may not be able to join:

People who are not currently enrolled as undergraduate students at NSU
People aged 17 or younger
Students who are currently receiving psychotherapy or mental health services
Students who have serious or urgent mental health needs, such as psychosis, active alcohol or drug use problems, or thoughts of suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kayla Thayer, Ph.D., ABPP, Nova Southeastern University

Phone: 954-262-5880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06652503

Sponsor: Nova Southeastern University

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 954-262-5880

More information: https://clinicaltrials.gov/study/NCT06652503

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older who are currently enrolled as undergraduate students at NSU (Nova Southeastern University)

Who may not be able to join:

People who are not currently enrolled as undergraduate students at NSU
People aged 17 or younger
Students who are currently receiving psychotherapy or mental health services
Students who have serious or urgent mental health needs, such as psychosis, active alcohol or drug use problems, or thoughts of suicide

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nova Southeastern University

Registry

ClinicalTrials.gov

Start date

13 January 2025

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participant anxiety symptom severity; Participant depression symptoms severity; Participant difficulties with emotion regulation; Participant Stress levels; Participant Resiliency; Participant quality of life and life satisfaction; Participant adaptive coping

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov